Lumibird SA (EPA: LBIRD)
France
· Delayed Price · Currency is EUR
9.64
-0.06 (-0.62%)
Jan 20, 2025, 5:35 PM CET
Lumibird Revenue
Lumibird had revenue of 99.24M EUR in the half year ending June 30, 2024, with 15.09% growth. This brings the company's revenue in the last twelve months to 207.33M, up 0.39% year-over-year. In the year 2023, Lumibird had annual revenue of 206.55M with 6.31% growth.
Revenue (ttm)
207.33M
Revenue Growth
+0.39%
P/S Ratio
1.02
Revenue / Employee
196.90K
Employees
989
Market Cap
212.07M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 206.55M | 12.26M | 6.31% |
Dec 31, 2022 | 194.29M | 27.91M | 16.77% |
Dec 31, 2021 | 166.39M | 36.88M | 28.48% |
Dec 31, 2020 | 129.51M | 16.85M | 14.96% |
Dec 31, 2019 | 112.65M | 10.86M | 10.67% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech | 2.74B |
bioMérieux | 3.81B |
Ipsen | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac | 1.34B |
Ramsay Générale de Santé | 5.01B |